http://biz.yahoo.com/prnews/030313/neth026_1.html
WASHINGTON, March 13 /PRNewswire/ — Senator Bill Frist (R-TN) introduced bill S. 15 Wednesday which will once again seek to protect drug companies from Thimerosal-related litigation while eliminating legal recourse for families of vaccine-injured, mercury-toxic children.
The new legislation, sponsored by Senator Judd Gregg, comes on the heels of a just-published report in the Journal of the American Association of Physicians and Surgeons. The research, conducted by Dr. Mark Geier and David Geier, analyzed mercury doses children received from Thimerosal in childhood vaccines in comparison to Federal Safety Guidelines. The doctors concluded that mercury from Thimerosal did exceed Federal Safety Guidelines and that the study provides “strong epidemiological evidence” for a link between increasing mercury from Thimerosal-containing childhood vaccines and neurodevelopmental disorders such as autism which has reached epidemic proportions. The authors stated, “A causal relationship between Thimerosal-containing childhood vaccines and neurodevelopmental disorders appears to be confirmed.”
The Geier research confirms the findings of an unreleased CDC study, obtained through the Freedom of Information Act, which found a relative risk of 2.48 between thimerosal exposures and autism. Courts of law have generally held that a relative risk of 2.0 or higher is sufficient to substantiate that a given exposure causes disease.
In 1990, the rate of autism was 1 in 10,000. Today that number stands at 1 in 150 according to Centers for Disease Control. This dramatic rise in autism rates correlates with the increase in mercury-exposure through vaccines given to children in the late 1980s and through the 1990s.